Attached files
| file | filename |
|---|---|
| EX-10.34 - EX-10.34 - Intra-Cellular Therapies, Inc. | d863619dex1034.htm |
| EX-31.2 - EX-31.2 - Intra-Cellular Therapies, Inc. | d863619dex312.htm |
| EX-31.1 - EX-31.1 - Intra-Cellular Therapies, Inc. | d863619dex311.htm |
| EX-23.1 - EX-23.1 - Intra-Cellular Therapies, Inc. | d863619dex231.htm |
| EX-10.33 - EX-10.33 - Intra-Cellular Therapies, Inc. | d863619dex1033.htm |
| EX-10.32 - EX-10.32 - Intra-Cellular Therapies, Inc. | d863619dex1032.htm |
| EX-10.28 - EX-10.28 - Intra-Cellular Therapies, Inc. | d863619dex1028.htm |
| EX-4.2 - EX-4.2 - Intra-Cellular Therapies, Inc. | d863619dex42.htm |
| 10-K - FORM 10-K - Intra-Cellular Therapies, Inc. | d863619d10k.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: March 2, 2020 |
/s/ Sharon Mates, Ph.D. | |||
| Sharon Mates, Ph.D. | ||||
| Chairman, President and Chief Executive Officer (principal executive officer) | ||||
| Dated: March 2, 2020 |
/s/ Lawrence J. Hineline | |||
| Lawrence J. Hineline | ||||
| Senior Vice President of Finance and Chief Financial Officer (principal financial officer and principal accounting officer) | ||||